Financial News

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Teva Pharmaceutical Industries ADR (NY: TEVA )

17.12 +0.04 (+0.23%)
Official Closing Price Updated: 7:00 PM EST, Nov 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Teva Pharmaceutical Industries ADR

< Previous 1 2 3 4 5 6 7 8 9
...
24 25 Next >
Teva Announces Approval of a Generic Version of Forteo® (teriparatide injection), in the U.S.
From Teva Pharmaceutical Industries Limited
Via Business Wire
Tuesday Talk: What's Going On?
The stock market rallied last week. The S&P 500 closed 51 points higher, the Dow closed 191 points higher, and the Nasdaq Composite closed 284 points higher. But is the rally real? 
Via Talk Markets
Topics Stocks
Exposures US Equities
Royalty Pharma and Teva Collaborate to Further Accelerate Olanzapine Lai Program
From Royalty Pharma plc
Via GlobeNewswire
Teva and Royalty Pharma Collaborate to Further Accelerate Olanzapine LAI Program
From Teva Pharmaceutical Industries Limited
Via Business Wire
Israel-Hamas War News: Top 15 Israeli-Based US-Traded Stocks Continue To Slide
The Israel-Hamas War is adversely affecting everything in Israel, including the stock performances of the 15 Israeli companies with market capitalizations of $2B or more that are listed on the Nasdaq... 
Via Talk Markets
Teva Pharmaceutical Industries (TEVA) Q3 2023 Earnings Call Transcript
TEVA earnings call for the period ending September 30, 2023. 
Via The Motley Fool
Topics Earnings
Exposures Financial
Teva Pharmaceutical Lifts Revenue Forecast - Huntington's And Migraine Drugs Help Q3 Performance
Teva Pharmaceutical Industries Ltd (NYSE: TEVA) reported Q3 sales of $3.85 billion, beating the consensus of $3.72 billion 
Via Benzinga
Teva Closes In On A Buy Point On Third-Quarter Beat, Business Separation
The company named a new chief executive for its Teva api business. 
Via Investor's Business Daily
US Stocks Set To Open Flat After Hot 7-Day Rally: Traders Sharpen Focus On Powell's Speech, Disney Earnings
Stock futures indicate a subdued opening on Wednesday after several consecutive gains in major averages. Traders are eagerly awaiting Federal Reserve Chair Jerome Powell’s speech for insights into... 
Via Benzinga
Topics Economy
Exposures Interest Rates
Teva Reports Third Quarter 2023 Financial Results and Increases Revenue Guidance
From Teva Pharmaceutical Industries Limited
Via Business Wire
Earnings Scheduled For November 8, 2023
Companies Reporting Before The Bell • Flex LNG (NYSE:FLNG) is estimated to report earnings for its third quarter. 
Via Benzinga
Teva appoints new CEO for Teva api, its Active Pharmaceutical Ingredients Business
From Teva Pharmaceutical Industries Limited
Via Business Wire
Teva to Present New Data Supporting Safety, Efficacy and Real-World Effectiveness of AUSTEDO® (deutetrabenazine) Tablets at the 2023 HSG Annual Meeting
From Teva Pharmaceutical Industries Limited
Via Business Wire
UZEDY™ (risperidone) Extended-Release Injectable Suspension Significantly Prolongs Time to Schizophrenia Relapse in RISE Study Results Published in The Lancet Psychiatry
From Teva Pharmaceutical Industries Limited
Via Business Wire
Alkermes Q3 Earnings Top Consensus, On Track To Separate Oncology Business, Reaffirms FY23 Outlook
Alkermes PLC (NASDAQ: ALKS) reported Q3 FY23 adjusted EPS of $0.64 compared to $0.02 a year ago, beating the  
Via Benzinga
Teva to Provide Second Round of Funding to Clinics in California, Florida and New Jersey as Part of $2 Million Commitment Through Community Routes: Access to Mental Health Care Program
From Teva Pharmaceutical Industries Limited
Via Business Wire
Roche Spends $7.1 Billion On Roivant Drug, Following Merck, Sanofi Into The Raging Hot Immunology Space
Roche is joining Merck and Sanofi in the TL1A drug space. These drugs could treat stomach diseases. 
Via Investor's Business Daily
Israeli-Hamas War: U.S. Exchange-Listed Israeli Stocks Continue To Decline
The 111 Israeli companies with stocks trading on US exchanges have combined market caps over $150B. Or at least they did midweek: since the Hamas-Israeli War began October 7th, pretty much everything... 
Via Talk Markets
Investor Exit Israel ETFs Following Attacks, But Remain Confident In Large-Caps
Israel-focused ETFs have plunged since the last trading day before Hamas launched surprise attacks on Israel, while some Israeli companies listed in the U.S. have so far escaped repercussions to their... 
Via Benzinga
Topics ETFs
Thoughts For Thursday: War Worries Rattle The Market
Via Talk Markets
Hamas-Israeli War: US Exchange Listed Israeli Stocks Hit Hard
111 Israeli companies trade on U.S. stock exchanges of which only 15 have market capitalization of $2B or more. 
Via Talk Markets
Teva Phase IV UNITE Study Shows AJOVY® (fremanezumab) Reduced Migraine Attacks and Depression Symptoms in Migraine Sufferers with Major Depressive Disorder
From Teva Pharmaceutical Industries Limited
Via Business Wire
Israel Could Form Emergency Government: Defense Stocks, Israel ETFs In Focus During Conflict
As Israel ramps up its armed forces and a regional war with Hamas enters its fourth day, the country is considering forming an emergency government. 
Via Benzinga
Topics ETFs
Israeli Stocks Fall as Investors Fear Middle East Conflict
The recent attacks on Israel will have a lasting economic impact. Here's what investors should know about Israeli stocks. 
Via InvestorPlace
Cathie Wood's ARK Israel Innovative Tech ETF Braces For Impact Amid Regional Warfare: 10 Stocks To Watch
Discover how Cathie Wood's ARK Israel Innovative Tech ETF responds to the Israel-Hamas conflict. Explore its portfolio performance and top Israeli stocks to watch amidst geopolitical turmoil. 
Via Benzinga
Topics ETFs
Why Teva Pharmaceutical (TEVA) Stock Is Falling
Teva Pharmaceutical Industries Ltd (NYSE: TEVA) shares are trading lower by 2.7% to $9.17 Monday morning amid conflict in the company's home country, Israel. 
Via Benzinga
Middle East War Hammers Israel-Based Stocks But Lifts Defense, Oil Names
Israel stocks, regardless of industry, sank Monday following the terrorist attack on Israel. 
Via Investor's Business Daily
Teva to Host Conference Call to Discuss Third Quarter 2023 Financial Results at 8 a.m. ET on November 8, 2023
From Teva Pharmaceutical Industries Limited
Via Business Wire
Palantir And PwC Team Up To Accelerate Data-Driven Operations, OpenAI Rival Secures Billions In Big Tech Backing, Six US States Brace For Healthcare Strike: Today's Top Stories
Benzinga 
Via Benzinga
Teva Pharma Hooks Sanofi In $1.5 Billion Inflammation Deal. But Shares Tumble.
The deal leans into the emerging TL1A drug class, potentially rivaling Roivant and Merck. 
Via Investor's Business Daily
< Previous 1 2 3 4 5 6 7 8 9
...
24 25 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Use the myMotherLode.com Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info
Terms of Service Privacy Policy
© Copyright 2000-2019 Clarke Broadcasting Corporation. All rights reserved.
Feedback